LAVA Therapeutics’ License Agreement with Seagen, Inc.

Armstrong Teasdale served as IP counsel to LAVA Therapeutics, while Ballard Spahr served as counsel on additional terms. Seagen Inc. (Nasdaq: SGEN), a world leader and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here